Help:Cleanup
From BugSigDB
This page assists editors with cleanup of certain outstanding wiki issues. It has lots of heavy queries so it may take a while to load or purge.
Links to lists of pages[edit source]
Duplicate Studies[edit source]
Orphaned Experiments[edit source]
Orphaned Signatures[edit source]
Studies that have no Experiments[edit source]
- A case report of malignant primary pericardial mesothelioma with atypical imaging appearance: multimodality imaging with histopathological correlation
- Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study
- [[1]]
- [[2]]
- [[3]]
- Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
- Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study
- Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects
- Recombinant Lactiplantibacilllus plantarum modulate gut microbial diversity and function
- Staphylococcus aureus susceptibility to complestatin and corbomycin depends on the VraSR two-component system
- Study 1030
- Study 1112
- Study 1120
- Study 1128
- Study 1134
- Study 1136
- Study 1137
- Study 1138
- Study 1153
- Study 1154
- Study 1155
- Study 1164
- Study 1171
- Study 1199
- Study 1273
- Study 1274
Experiments that have no Signatures[edit source]
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 4
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 5
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 6
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 7
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 8
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 9
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 10
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 11
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 12
- A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women/Experiment 13
- Acupoint Massage Therapy Alters the Composition of Gut Microbiome in Functional Constipation Patients/Experiment 1
- Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease/Experiment 4
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 30
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 31
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 32
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 33
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 34
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 35
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 36
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 37
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 38
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 39
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 40
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 41
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 42
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 43
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 44
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 45
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 46
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 47
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 48
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 49
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 50
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 51
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 52
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 53
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 54
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 55
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 56
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 57
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 58
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 59
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 60
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 61
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 62
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 63
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 64
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 65
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 66
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 67
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 68
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 69
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 70
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 71
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 72
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 73
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 74
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 75
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 76
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 77
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 78
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 79
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 80
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 81
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 82
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 83
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 84
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 85
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 86
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 87
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 88
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 89
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 90
- Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 3
- Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status/Experiment 1
- Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy/Experiment 3
- Altered composition of the gut microbiome in patients with drug-resistant epilepsy/Experiment 2
- Antibiotics at birth and later antibiotic courses: effects on gut microbiota/Experiment 2
- Changes in Bacteroides and the microbiota in patients with obstructed colorectal cancer: retrospective cohort study/Experiment 2
- Changes in the gut microbiome associated with infliximab in patients with bipolar disorder/Experiment 1
- Changes in the Gut Microbiota of Children with Autism Spectrum Disorder/Experiment 2
- Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension/Experiment 1
- Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension/Experiment 2
- Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension/Experiment 3
- Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension/Experiment 7
- Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension/Experiment 8
- Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension/Experiment 9
- Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension/Experiment 10
- Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes/Experiment 2
- Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes/Experiment 3
- Characteristics of the oral and gastric microbiome in patients with early-stage intramucosal esophageal squamous cell carcinoma/Experiment 2
- Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors: A Chinese population-based study/Experiment 2
- Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 8
- Comparative analysis of racial differences in breast tumor microbiome/Experiment 3
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 13
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 14
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 17
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 18
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 21
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 22
- Composition and Functional Potential of the Human Mammary Microbiota Prior to and Following Breast Tumor Diagnosis/Experiment 4
- Composition and Functional Potential of the Human Mammary Microbiota Prior to and Following Breast Tumor Diagnosis/Experiment 5
- Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns/Experiment 1
- Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation/Experiment 2
- Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation/Experiment 3
- Differences in foot skin microbiomes between patients with type 2 diabetes and healthy individuals/Experiment 2
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 8
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 9
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 10
- Different Efficacy of Five Soluble Dietary Fibers on Alleviating Loperamide-Induced Constipation in Mice: Influences of Different Structural Features/Experiment 1
- Differential Responses to Dietary Protein and Carbohydrate Ratio on Gut Microbiome in Obese vs. Lean Cats/Experiment 1
- Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma/Experiment 4
- Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma/Experiment 5
- Dysbiosis of saliva microbiome in patients with oral lichen planus/Experiment 2
- Dysbiosis of saliva microbiome in patients with oral lichen planus/Experiment 3
- Dysbiosis of saliva microbiome in patients with oral lichen planus/Experiment 6
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 9
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 10
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 11
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 12
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 13
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 14
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 15
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 16
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 17
- Effect of endometriosis on the fecal bacteriota composition of mice during the acute phase of lesion formation/Experiment 1
- Effect of endometriosis on the fecal bacteriota composition of mice during the acute phase of lesion formation/Experiment 2
- Effect of endometriosis on the fecal bacteriota composition of mice during the acute phase of lesion formation/Experiment 3
- Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia/Experiment 1
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 9
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 10
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 16
- 39454570/Experiment 4
- 39454570/Experiment 5
- Effects of removing in-feed antibiotics and zinc oxide on the taxonomy and functionality of the microbiota in post weaning pigs/Experiment 4
- Effects of removing in-feed antibiotics and zinc oxide on the taxonomy and functionality of the microbiota in post weaning pigs/Experiment 5
- Effects of removing in-feed antibiotics and zinc oxide on the taxonomy and functionality of the microbiota in post weaning pigs/Experiment 6
- Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 3
- Enrichment of human nasopharyngeal bacteriome with bacteria from dust after short-term exposure to indoor environment: a pilot study/Experiment 2
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 4
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 5
- Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai/Experiment 2
- Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls/Experiment 1
- Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor/Experiment 2
- Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor/Experiment 3
- Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor/Experiment 4
- External light-dark cycle shapes gut microbiota through intrinsically photosensitive retinal ganglion cells/Experiment 2
- Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 4
- Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 8
- Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 10
- Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 11
- Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 15
- Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 20
- Favorable subgingival plaque microbiome shifts are associated with clinical treatment for peri-implant diseases/Experiment 1
- Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis/Experiment 4
- 34690948/Experiment 1
- Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ, and healthy women/Experiment 12
- Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ, and healthy women/Experiment 14
- Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion/Experiment 4
- Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 11
- 40189515/Experiment 1
- Gut microbiome in patients with early-stage and late-stage endometriosis/Experiment 2
- 40189515/Experiment 3
- 40189515/Experiment 4
- Gut microbiome in patients with early-stage and late-stage endometriosis/Experiment 5
- Gut Microbiota Alterations and Their Functional Differences in Depression According to Enterotypes in Asian Individuals/Experiment 3
- Gut microbiota differences in stunted and normal-lenght children aged 36-45 months in East Nusa Tenggara, Indonesia/Experiment 8
- Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy/Experiment 2
- Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 12
- [3]
- Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 22
- Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 23
- Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 24
- Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 46
- Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 47
- Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition/Experiment 48
- Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis/Experiment 1
- Intestinal microbiome analysis demonstrates azithromycin post-treatment effects improve when combined with lactulose/Experiment 8
- Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 14
- Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 15
- Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 16
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 7
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 8
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 9
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 10
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 11
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 12
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 13
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 1
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 3
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 4
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 5
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 6
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 8
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 9
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 10
- Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 2
- Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 3
- Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 4
- Maternal microbiota communicates with the fetus through microbiota-derived extracellular vesicles/Experiment 3
- Maternal microbiota communicates with the fetus through microbiota-derived extracellular vesicles/Experiment 4
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 5
- Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese/Experiment 1
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 7
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 8
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 9
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 10
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 11
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 12
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 13
- Microbiome analysis reveals gut microbiota alteration of early-weaned Yimeng black goats with the effect of milk replacer and age/Experiment 14
- Microbiome and diversity indices during blood stem cells transplantation - new perspectives?/Experiment 1
- Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 2
- Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups/Experiment 3
- Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients/Experiment 1
- Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study/Experiment 8
- Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study/Experiment 15
- Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study/Experiment 16
- Oral microbiota of patients with phenylketonuria: A nation-based cross-sectional study/Experiment 17
- PandaGUT provides new insights into bacterial diversity, function, and resistome landscapes with implications for conservation/Experiment 2
- PandaGUT provides new insights into bacterial diversity, function, and resistome landscapes with implications for conservation/Experiment 3
- Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic/Experiment 2
- Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome/Experiment 3
- Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease/Experiment 1
- Resilience of the respiratory microbiome in controlled adult RSV challenge study/Experiment 1
- Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients/Experiment 11
- Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients/Experiment 12
- Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 5
- Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 6
- Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 7
- Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 8
- Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 9
- 39976263/Experiment 10
- Roseburia hominis improves host metabolism in diet-induced obesity/Experiment 11
- SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition/Experiment 1
- Six-month follow-up of gut microbiota richness in patients with COVID-19/Experiment 1
- Six-month follow-up of gut microbiota richness in patients with COVID-19/Experiment 2
- Smoking and salivary microbiota: a cross-sectional analysis of an Italian alpine population/Experiment 2
- Social isolation induces intestinal barrier disorder and imbalances gut microbiota in mice/Experiment 1
- Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 1
- Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 5
- Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 6
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 1
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 2
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 3
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 4
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 5
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 6
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 7
- The Airway Microbiota Signatures of Infection and Rejection in Lung Transplant Recipients/Experiment 1
- The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease/Experiment 3
- The clinical outcomes of medical therapies in chronic rhinosinusitis are independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial/Experiment 1
- The impact of postnatal antibiotics on the preterm intestinal microbiome/Experiment 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 9
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 10
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 11
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 12
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 13
- The potential of fecal microbiota and amino acids to detect and monitor patients with adenoma/Experiment 2
- Types of tobacco consumption and the oral microbiome in the United Arab Emirates Healthy Future (UAEHFS) Pilot Study/Experiment 6
- Types of tobacco consumption and the oral microbiome in the United Arab Emirates Healthy Future (UAEHFS) Pilot Study/Experiment 7
- Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 + /Experiment 1
- Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 + /Experiment 4
- Vaginal Microbiome Metagenome Inference Accuracy: Differential Measurement Error according to Community Composition/Experiment 1
- White-nose syndrome restructures bat skin microbiomes/Experiment 2
- Yearly variation coupled with social interactions shape the skin microbiome in free-ranging rhesus macaques/Experiment 2
- Yearly variation coupled with social interactions shape the skin microbiome in free-ranging rhesus macaques/Experiment 3
- Yearly variation coupled with social interactions shape the skin microbiome in free-ranging rhesus macaques/Experiment 4
- Yearly variation coupled with social interactions shape the skin microbiome in free-ranging rhesus macaques/Experiment 5
